On 09 May 2018
Jubilant Life Sciences will hold a meeting of the Board of Directors of the Company on 09 May 2018, to inter-alia consider Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018, and recommendation of Dividend for the Financial Year ended March 31, 2018.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
